Description
RADIOPHARMACEUTICAL 521C05047 DEOBLIGATION OF EXCESS FUNDS
Base award description: RADIOPHARMACEUTICAL IGF::OT::IGF
Modification chain · 17 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2017-10-10+$108,250= $108,250
- Mod P000012017-10-11+$0= $108,250
- Mod P000022018-10-02+$111,498= $219,747
- Mod P000032019-06-14-$46,271= $173,476
- Mod P000042019-07-25-$6,677= $166,798
- Mod P000052019-07-29+$0= $166,798
- Mod P000062019-07-30+$0= $166,798
- Mod P000072019-08-01+$30,000= $196,798
- Mod P000082019-10-01+$114,842= $311,641
- Mod P000092020-04-09+$46,532= $358,172
- Mod P000102020-04-10+$0= $358,172
- Mod P000132020-10-20-$1,139= $357,033
- Mod P000142020-11-05-$12,142= $344,891
- Mod P000152020-12-17+$10,955= $355,846
- Mod P000162021-04-20+$9,360= $365,206
- Mod P000172021-07-01+$9,079= $374,285
- Mod P000182021-08-23-$46= $374,239
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2017-10-10 | +$108,250 | $108,250 | RADIOPHARMACEUTICAL IGF::OT::IGF |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2017-10-11 | +$0 | $108,250 | RADIOPHARMACEUTICAL IGF::OT::IGF |
| Mod P00002· EXERCISE AN OPTION | 2018-10-02 | +$111,498 | $219,747 | RADIOPHARMACEUTICAL IGF::OT::IGF |
| Mod P00003· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2019-06-14 | −$46,271 | $173,476 | RADIOPHARMACEUTICAL IGF::OT::IGF |
| Mod P00004· CHANGE ORDER | 2019-07-25 | −$6,677 | $166,798 | RADIOPHARMACEUTICAL IGF:OT:IGF |
| Mod P00005· OTHER ADMINISTRATIVE ACTION | 2019-07-29 | +$0 | $166,798 | RADIOPHARMACEUTICAL IGF:OT:IGF |
| Mod P00006· OTHER ADMINISTRATIVE ACTION | 2019-07-30 | +$0 | $166,798 | RADIOPHARMACEUTICAL IGF:OT:IGF |
| Mod P00007· OTHER ADMINISTRATIVE ACTION | 2019-08-01 | +$30,000 | $196,798 | RADIOPHARMACEUTICAL IGF:OT:IGF |
| Mod P00008· EXERCISE AN OPTION | 2019-10-01 | +$114,842 | $311,641 | RADIOPHARMACEUTICAL IGF:OT:IGF |
| Mod P00009· FUNDING ONLY ACTION | 2020-04-09 | +$46,532 | $358,172 | RADIOPHARMACEUTICAL IGF:OT:IGF |
| Mod P00010· OTHER ADMINISTRATIVE ACTION | 2020-04-10 | +$0 | $358,172 | RADIOPHARMACEUTICAL IGF:OT:IGF |
| Mod P00013· FUNDING ONLY ACTION | 2020-10-20 | −$1,139 | $357,033 | RADIOPHARMACEUTICAL 521C95264 EXCESS FUNDS DEOBLIGATION |
| Mod P00014· FUNDING ONLY ACTION | 2020-11-05 | −$12,142 | $344,891 | RADIOPHARMACEUTICAL 521A90002 EXCESS FUNDS DEOBLIGATION |
| Mod P00015· FUNDING ONLY ACTION | 2020-12-17 | +$10,955 | $355,846 | RADIOPHARMACEUTICAL 521C05047 ADDITIONAL FUNDS OBLIGATION |
| Mod P00016· OTHER ADMINISTRATIVE ACTION | 2021-04-20 | +$9,360 | $365,206 | RADIOPHARMACEUTICAL 521C05047 ADDITIONAL FUNDS OBLIGATION |
| Mod P00017· OTHER ADMINISTRATIVE ACTION | 2021-07-01 | +$9,079 | $374,285 | RADIOPHARMACEUTICAL 521C05047 ADDITIONAL FUNDS OBLIGATION |
| Mod P00018· FUNDING ONLY ACTION | 2021-08-23 | −$46 | $374,239 | RADIOPHARMACEUTICAL 521C05047 DEOBLIGATION OF EXCESS FUNDS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI N25KC4APTJ98)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25026P0572 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $384,719 | FY2026 |
| 36C25225P0344 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $13,214 | FY2025 |
| 36C24924P1063 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $31,930 | FY2024 |
| 36C24724P0588 | 247-NETWORK CONTRACT OFFICE 7 (36C247) · 6505 · DRUGS AND BIOLOGICALS | $11,676 | FY2024 |
| 36C24624P0018 | 246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6505 · DRUGS AND BIOLOGICALS | $758,739 | FY2024 |
| 36C24823P2589 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $307,115 | FY2023 |
Other recipients under Q509 from 247-NETWORK CONTRACT OFFICE 7 (36C247) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24726P0144 | TITAN-AUXO, LLC | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $555,829 | FY2026 |
| 36C24722F0677 | SPECTRUM HEALTHCARE RESOURCES, INC | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $426,817 | FY2022 |
| 36C24722F0413 | SPECTRUM HEALTHCARE RESOURCES, INC | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $1,788,063 | FY2022 |
| 36C24722C0034 | TOP DOCS, INC. | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $0 | FY2022 |
| 36C24721C0089 | MEDICAL UNIVERSITY OF SOUTH CAROLINA | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $355,008 | FY2021 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24718C0004_3600_-NONE-_-NONE- · retrieved 2026-09-26.